PAHC

56.24

2.85% 1.56

Handel nachbörslich: 56.39 0.15 +0.27%

Phibro Animal Health Corp (PAHC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

$54.68

Offen:

$55.15

24-Stunden-Volumen:

185.37K

Relative Volume:

0.63

Marktkapitalisierung:

$2.28B

Einnahmen:

$1.46B

Nettoeinkommen (Verlust:

$92.09M

KGV:

24.93

EPS:

2.2555

Netto-Cashflow:

$47.29M

1W Leistung:

+3.59%

1M Leistung:

+1.30%

6M Leistung:

+36.67%

1J Leistung:

+187.97%

1-Tages-Spanne:

$55.07

$57.17

1-Wochen-Bereich:

$51.09

$57.17

52-Wochen-Spanne:

$18.89

$60.08

Phibro Animal Health Corp Stock (PAHC) Company Profile

Firmenname

Phibro Animal Health Corp

Sektor

Healthcare (1106)

Branche

Drug Manufacturers - Specialty & Generic (84)

Telefon

201-329-7300

Adresse

GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ

Mitarbeiter

2,475

Twitter

@phibroeurope

Nächster Verdiensttermin

2026-05-06

Neueste SEC-Einreichungen

PAHC's Discussions on Twitter

Compare PAHC vs TAK, ZTS, TEVA, HLN, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PAHC Phibro Animal Health Corp	56.24	2.22B	1.46B	92.09M	47.29M	2.2555
TAK Takeda Pharmaceutical Co Adr	16.55	52.32B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	112.54	47.38B	9.47B	2.67B	2.28B	6.0218
TEVA Teva Pharmaceutical Industries Ltd Adr	35.86	41.16B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.17	41.02B	14.54B	2.22B	2.58B	0.4871
UTHR United Therapeutics Corp	572.20	24.67B	3.18B	1.33B	1.04B	27.90

Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-15	Eingeleitet	Citigroup	Neutral
2025-07-07	Hochstufung	JP Morgan	Neutral → Overweight
2025-06-16	Hochstufung	BNP Paribas Exane	Underperform → Neutral
2024-09-10	Eingeleitet	JP Morgan	Neutral
2023-12-07	Eingeleitet	Exane BNP Paribas	Underperform
2022-12-21	Eingeleitet	ROTH Capital	Buy
2022-07-25	Herabstufung	Barclays	Equal Weight → Underweight
2022-01-10	Hochstufung	Barclays	Underweight → Equal Weight
2021-11-18	Eingeleitet	Morgan Stanley	Equal-Weight
2021-08-05	Fortgesetzt	Credit Suisse	Neutral
2021-07-07	Herabstufung	Barclays	Equal Weight → Underweight
2020-08-06	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2020-02-06	Herabstufung	Gabelli & Co	Buy → Hold
2020-01-28	Hochstufung	Barclays	Underweight → Equal Weight
2019-09-05	Hochstufung	Morgan Stanley	Underweight → Equal-Weight
2019-08-29	Bestätigt	BofA/Merrill	Underperform
2019-06-11	Eingeleitet	Barclays	Underweight
2019-05-23	Eingeleitet	Guggenheim	Neutral
2019-05-09	Hochstufung	Gabelli & Co	Hold → Buy
2017-08-23	Fortgesetzt	BofA/Merrill	Underperform
2017-06-02	Herabstufung	Credit Suisse	Outperform → Neutral
2016-12-15	Eingeleitet	Piper Jaffray	Overweight
2016-11-11	Herabstufung	Macquarie	Neutral → Underperform
2016-11-10	Herabstufung	Gabelli & Co	Buy → Hold
2016-04-11	Bestätigt	Guggenheim	Buy
2016-02-04	Eingeleitet	Credit Suisse	Outperform
2016-01-15	Herabstufung	Barclays	Overweight → Underweight
2015-09-30	Eingeleitet	Gabelli & Co	Buy
2015-04-24	Bestätigt	Barclays	Overweight
2015-04-21	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2014-05-06	Eingeleitet	Barclays	Overweight

Alle ansehen

Phibro Animal Health Corp Aktie (PAHC) Neueste Nachrichten

May 05, 2026

Phibro Animal Health Corporation Launches Companywide Sustainable - The National Law Review

May 05, 2026

[8-K] PHIBRO ANIMAL HEALTH CORP Reports Material Event - Stock Titan

May 05, 2026

Phibro sets June 24 payout for $0.12-a-share quarterly dividend - Stock Titan

May 05, 2026

Phibro launches low-carbon feed ingredients to target Scope 3 emissions - Stock Titan

May 05, 2026

May 04, 2026

How Investors Are Reacting To Phibro Animal Health (PAHC) Expanding Its Revolving Credit Facility - Yahoo Finance

May 04, 2026

MSN Money - MSN

May 04, 2026

May 01, 2026